comparemela.com
Home
Live Updates
Jasper Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update : comparemela.com
Jasper Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Business Update
First Patient Dosed in Phase 1 trial of Briquilimab in Lower-Risk Myelodysplastic SyndromeStrengthened the Board of Directors and Management Team with Multiple Appointments REDWOOD CITY, Calif., Aug....
Related Keywords
United States ,
Edwinj Tucker ,
Patricia Carlos ,
Stephenj Galli ,
Ronald Martell ,
Daniel Adelman ,
John Mullaly ,
Scott Brun ,
Lauren Barbiero ,
Annette Marcantonio ,
Jasper Therapeutics Inc ,
Moffitt Cancer Center ,
Nasdaq ,
Management Team ,
Development Rd Expenses ,
Equality Affairs ,
First Patient Dosed ,
Lower Risk Myelodysplastic ,
Chief Executive Officer ,
Scientific Advisory ,
Chief Medical ,
Senior Vice President ,
Vice President ,
Cash Equivalents ,
Chronic Spontaneous Urticaria ,
Intermediate Risk ,
Annual Report ,
Months Ended June ,
Stockholder Equity ,
comparemela.com © 2020. All Rights Reserved.